Loading
NeoRecormon is a man-made copy of erythropoietin, the hormone that tells the marrow to make red blood cells. In cancer care it treats anaemia that is causing symptoms in adults having chemotherapy for cancers that do not start in the marrow's myeloid cells.
Epoetin beta (NeoRecormon; marketing authorisation holder Roche Registration GmbH) has been authorised in the EU since July 1997 (CHMP opinion 16 October 1996; the EMA page gives 16 July 1997 in its authorisation details and 17 July 1997 in its overview). Its indications are symptomatic anaemia in chronic renal failure in adults and children, symptomatic anaemia in adults with non-myeloid malignancies receiving chemotherapy, and increasing the yield of blood donated before major planned surgery; the overview also lists preventing anaemia in premature babies. In the studies the EMA summarises, 1,204 patients with different cancers were compared with placebo, and it reduced the need for transfusion in people receiving chemotherapy. The corpus's other erythropoiesis-stimulating agents are epoetin alfa, epoetin theta and darbepoetin alfa.
A copy of the human hormone erythropoietin, which is made by the kidneys and tells the bone marrow to make red blood cells; it works in the body in the same way as the natural hormone (EPAR overview, EMA). Connects to Erythropoietin receptor (EPOR).
1.Epoetin beta slips into a pocket on Erythropoietin receptor (EPOR).
| Region | Year | Indication |
|---|---|---|
| EU | 1997 | Symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy; anaemia of chronic renal failure; autologous blood pre-donation · Authorised July 1997 (16 Jul in the authorisation details, 17 Jul in the overview); Roche Registration GmbH |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Epoetin beta" OR ABSTRACT:"Epoetin beta" OR TITLE:"NeoRecormon" OR ABSTRACT:"NeoRecormon" OR TITLE:"epoetin beta" OR ABSTRACT:"epoetin beta") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Epoetin beta, not a curated reading list.
Shares the tags universe-gap, ema-register, supportive.
Shares the tags ema-register, supportive.
Shares the tags ema-register, supportive.
Shares the tags ema-register, supportive.
Shares the tags universe-gap, supportive.
Shares the tags universe-gap, ema-register.
Shares the tags universe-gap, ema-register.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/